Biocryst Pharmaceuticals (BCRX) Cash from Financing Activities (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Cash from Financing Activities of -$11.15 million for Q2 2026, compared with -$73.69 million a year earlier.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Biocryst Pharmaceuticals was $124.63 million; for FY2025, it was -$349.93 million.
- In prior years, Biocryst Pharmaceuticals' Cash from Financing Activities was -$5.76 million in FY2024, $32.49 million in FY2023 (-63.1%), $88.03 million in FY2022 (-75.5%) and $359.67 million in FY2021 (+19.7%).
- Quarterly Cash from Financing Activities has run from a low of -$217.96 million in Q4 2025 to a high of $412.55 million in Q1 2026 over five years.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $412.55 million (Q1 2026), -$217.96 million (Q4 2025) and -$58.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | -11.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.15 Mn |
| Mar 31, 2026 | 412.55 Mn |
| Dec 31, 2025 | -217.96 Mn |
| Sep 30, 2025 | -58.81 Mn |
| Jun 30, 2025 | -73.69 Mn |
| Mar 31, 2025 | 529,000.00 |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -1.97 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -3.17 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 29.36 Mn |
| Mar 31, 2023 | 5.08 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 76.33 Mn |
| Jun 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | 347.42 Mn |
| Sep 30, 2021 | 4.78 Mn |
API Access
Biocryst Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();